View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHempshire Group 過去の業績過去 基準チェック /06Hempshire Groupの収益は年間平均-284.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間9.7% 52%割合で 減少しています。主要情報-284.32%収益成長率-87.88%EPS成長率Pharmaceuticals 業界の成長5.95%収益成長率-51.97%株主資本利益率-341.45%ネット・マージン-4,683.02%前回の決算情報30 Sep 2022最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.お知らせ • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.お知らせ • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.お知らせ • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.お知らせ • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.収支内訳Hempshire Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:HMPS.F 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 220-72030 Jun 220-62031 Mar 220-32031 Dec 210-22031 Dec 200000質の高い収益: HMPS.Fは現在利益が出ていません。利益率の向上: HMPS.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: HMPS.Fは株式公開されてから 3 年未満しか経っていないため、過去 5 年間の前年比収益成長率がプラスであったかどうかを判断できません。成長の加速: HMPS.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: HMPS.Fは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( -5% ) と比較することは困難です。株主資本利益率高いROE: HMPS.Fは現在利益が出ていないため、自己資本利益率 ( -341.45% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/12/06 16:28終値2022/09/08 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Hempshire Group, Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 01The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended.
お知らせ • Jun 27The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024.
お知らせ • Feb 15+ 1 more updateHempshire Group Announces CEO ChangesThe Hempshire Group, Inc. announced that Alex Shegelman, Chief Executive Officer, has advised the Board of Directors that he will retire as Chief Executive Officer effective February 14, 2024, to focus on other commitments. Mr. Shegelman also advised that he will remain on the Board of Directors of the Company. The Board of Directors has appointed Mr. Tom Shuman Chief Executive Officer of Hempshire. Mr. Shuman helped found Hempshire and brings more than 30 years of experience leading CPG sales and marketing teams, both as a founder and executive in various roles. He has extensive experience working across the full sales chain, including with brokers, distributors, wholesalers and retailers, for companies such as Procter & Gamble, Coca-Cola and Dr. Pepper/SevenUp.
お知らせ • Sep 13The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers.
お知らせ • Jul 01The Hempshire Group, Inc. Announces Board ChangesThe Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams.
お知らせ • Jun 13The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting.